Acorda drops experimental Parkinson’s drug

21st November 2017 Uncategorised 0

US biotech Acorda Therapeutics is discontinuing development of its experimental Parkinson’s disease therapy tozadenant on concerns over patient safety.

More: Acorda drops experimental Parkinson’s drug
Source: News